Literature DB >> 29022570

Arterial stiffness as a risk factor for clinical hypertension.

Michel E Safar1.   

Abstract

In patients with uncomplicated essential hypertension, cardiac output remains within normal ranges and intravascular volume is normal or low, assuming the presence of a sufficient Windkessel effect and usual resistance and compliance calculations. However, mean circulatory pressure is elevated in these patients. In addition, vascular resistance is augmented, and most importantly, the viscoelasticity of the cardiovascular system is substantially impaired. Such considerations are essential to understanding the mechanisms behind carotid-femoral arterial stiffness, a major risk factor in individuals with hypertension. Arterial stiffness, measured from pulse wave velocity, is substantially increased in hypertension even independently of blood pressure levels. Structural vascular changes and endothelial dysfunction are consistently associated with vessel impairments in animal models of hypertension. Increased arterial stiffness has a major effect on pulse pressure (the difference between systolic and diastolic blood pressure), wave reflections, kidney function, and above all, cardiovascular risk. This increased cardiovascular risk is particularly deleterious in patients with hypertension and/or type 2 diabetes mellitus, who are at risk of both renal and cardiovascular events. In this Review, we discuss the importance of arterial stiffness in the diagnosis and management of hypertension and the need for new approaches for the treatment of hypertension in patients with or without diabetes and/or renal impairment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29022570     DOI: 10.1038/nrcardio.2017.155

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  81 in total

Review 1.  Pulse pressure, arterial stiffness, and drug treatment of hypertension.

Authors:  L M Van Bortel; H A Struijker-Boudier; M E Safar
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.

Authors:  A Benetos; M Safar; A Rudnichi; H Smulyan; J L Richard; P Ducimetieère; L Guize
Journal:  Hypertension       Date:  1997-12       Impact factor: 10.190

3.  Aortic stiffness is an independent predictor of fatal stroke in essential hypertension.

Authors:  Stéphane Laurent; Sandrine Katsahian; Céline Fassot; Anne-Isabelle Tropeano; Isabelle Gautier; Brigitte Laloux; Pierre Boutouyrie
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

4.  Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension.

Authors:  Andrew D Stewart; Benyu Jiang; Sandrine C Millasseau; James M Ritter; Philip J Chowienczyk
Journal:  Hypertension       Date:  2006-08-14       Impact factor: 10.190

Review 5.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

6.  Meaning of the cardiac output-blood volume relationship in essential hypertension.

Authors:  N P Chau; T G Coleman; G M London; M E Safar
Journal:  Am J Physiol       Date:  1982-09

7.  Intraaortic pulse pressure amplification in subjects at high coronary risk.

Authors:  Mohamed Temmar; Piotr Jankowski; Marcel Peltier; Vincent Mouquet; Dorota Debicka-Dabrowska; Farah Hamida; Kalina Kawecka-Jaszcz; Michel E Safar
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

8.  Sex difference in cardiovascular risk: role of pulse pressure amplification.

Authors:  Véronique Regnault; Frédérique Thomas; Michel E Safar; Mary Osborne-Pellegrin; Raouf A Khalil; Bruno Pannier; Patrick Lacolley
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

Review 9.  Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.

Authors:  Yoav Ben-Shlomo; Melissa Spears; Chris Boustred; Margaret May; Simon G Anderson; Emelia J Benjamin; Pierre Boutouyrie; James Cameron; Chen-Huan Chen; J Kennedy Cruickshank; Shih-Jen Hwang; Edward G Lakatta; Stephane Laurent; João Maldonado; Gary F Mitchell; Samer S Najjar; Anne B Newman; Mitsuru Ohishi; Bruno Pannier; Telmo Pereira; Ramachandran S Vasan; Tomoki Shokawa; Kim Sutton-Tyrell; Francis Verbeke; Kang-Ling Wang; David J Webb; Tine Willum Hansen; Sophia Zoungas; Carmel M McEniery; John R Cockcroft; Ian B Wilkinson
Journal:  J Am Coll Cardiol       Date:  2013-11-13       Impact factor: 24.094

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  67 in total

1.  LIMK (LIM Kinase) Inhibition Prevents Vasoconstriction- and Hypertension-Induced Arterial Stiffening and Remodeling.

Authors:  Mariana Morales-Quinones; Francisco I Ramirez-Perez; Christopher A Foote; Thaysa Ghiarone; Larissa Ferreira-Santos; Maria Bloksgaard; Nicole Spencer; Eric T Kimchi; Camila Manrique-Acevedo; Jaume Padilla; Luis A Martinez-Lemus
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

2.  Evaluation of aortic stiffness by a new simplified 2D speckle tracking analysis.

Authors:  Luca Sabia; Eleonora Avenatti; Marco Cesareo; Dario Leone; Francesco Tosello; Franco Veglio; Alberto Milan
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-21       Impact factor: 2.357

3.  Blockade of angiotensin AT1 receptors prevents arterial remodelling and stiffening in iron-overloaded rats.

Authors:  Helbert Gabriel Fidelis; Jandinay Gonzaga Alexandre Mageski; Susana Curry Evangelista Goes; Tatiani Botelho; Vinicius Bermond Marques; Renata Andrade Ávila; Leonardo Dos Santos
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

4.  TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice.

Authors:  Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

Review 5.  Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.

Authors:  Emily A Pinheiro; Tarek Magdy; Paul W Burridge
Journal:  J Cardiovasc Transl Res       Date:  2020-02-20       Impact factor: 4.132

6.  Waveform analysis of human retinal and choroidal blood flow with laser Doppler holography.

Authors:  Léo Puyo; Michel Paques; Mathias Fink; José-Alain Sahel; Michael Atlan
Journal:  Biomed Opt Express       Date:  2019-09-05       Impact factor: 3.732

Review 7.  Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2018-07-06       Impact factor: 5.369

Review 8.  Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall.

Authors:  Patricia Martinez-Quinones; Cameron G McCarthy; Stephanie W Watts; Nicole S Klee; Amel Komic; Fabiano B Calmasini; Fernanda Priviero; Alexander Warner; Yu Chenghao; Camilla F Wenceslau
Journal:  Am J Hypertens       Date:  2018-09-11       Impact factor: 2.689

Review 9.  Arterial Stiffness in Hypertension: an Update.

Authors:  Korshie Dumor; Michael Shoemaker-Moyle; Ravi Nistala; Adam Whaley-Connell
Journal:  Curr Hypertens Rep       Date:  2018-07-04       Impact factor: 5.369

Review 10.  Cardiovascular diseases, cold exposure and exercise.

Authors:  Tiina M Ikäheimo
Journal:  Temperature (Austin)       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.